Placenta Previa Clinical Trial
Official title:
Relation of Implantation Site to Placental Site in Presence or Absence of Cesarean Section Scar With Doppler Assessment of Retro Chorionic Blood Flow
After gaining verbal consent , Patients included in this study will be subjected to:
1. history taking :
- peronal history .
- obstetric history.
- past history
2. general examination including vital signs
3. abominal and pelvic examination
4. the patient will be examined son graphically at 3 visits
1. The first visit at less than 10 weeks gestation :trans vaginal ultrasound with
partially filled bladder to nullify effect of anteversion of the uterus for
assessment of---the site of the intrauterine gestational sac in relation to the
endometrial cavity . For the purposes of this study and to obtain consistent
findings, it was decided to have only five subgroups of gestational site
implantation in relation to the endometrial cavity (Fig. 2):
1. anterior,
2. posterior,
3. Fundal,
4. low-lying anterior,\
5. low lying posterior We adopted the definition of implantation site from
previous publication (Abdallah et al., 2012). The implantation site is
visualized in the sagittal plane as a hyperechoic ring that occupies one side
of the implanted gestational sac and protrudes into the endometrial lumen It
represents the maternal decidual reaction and the beginning of maternal-fetal
circulation. This area is also believed to be responsible for future placental
formation and development (Brosens and Gellersen, 2010) Distance between the
implantation site and the internal cervical ostium (os). This was taken from
the lower end of the hyperechoic trophoblast ring of the gestational sac to
the internal cervical os in the sagittal plane.
- doppler assessment of the retro chorionic blood flow in the area behind
the maximum chorionic tissue to detect sensitivity index (RI),in cases of
low gestational sac Doppler assessment of peri trophoplastic blood flow
will be assessed.
2. then the patient will be enrolled during routine ANC till delivery and data
collected at32-34 weeks gestation regarding placental site will be correlated with
1st data and data at delivery
Status | Not yet recruiting |
Enrollment | 200 |
Est. completion date | September 30, 2018 |
Est. primary completion date | August 31, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - singleton intrauterine pregnancy. - gestational age less than 10 weeks - history of previous cesarean section(one or more) Exclusion Criteria: - negative fetal pole pulsation. - any condition distorting uterine cavity i.e uterine myoma,uterine cavity anomalies - multifetal pregnancy. - any condition necessitate termination of early pregnancy i.e maternal medical disorder ,molar pregnancy. |
Country | Name | City | State |
---|---|---|---|
Egypt | Kasr Alainy medical school | Cairo |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Placenta previa | measuring the distance between lower placental edge and internal os of the cervix by ultrasound | at 36 weeks of gestational age |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04518163 -
Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa
|
N/A | |
Recruiting |
NCT04518150 -
Combined Bilateral Uterine Artery Ligation and Bakri Balloon During Cesarean Section
|
N/A | |
Recruiting |
NCT03638024 -
Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
|
||
Terminated |
NCT01996345 -
Vaginal Pessary Versus Expectant Management for Placenta Previa
|
N/A | |
Recruiting |
NCT04609527 -
Management of Placenta Accreta Spectrum
|
Phase 2/Phase 3 | |
Completed |
NCT03431116 -
Low Implanted Second Trimester Placenta and Placenta Previa
|
N/A | |
Completed |
NCT03321435 -
The Placenta Previa and Fetal Weight
|
N/A | |
Enrolling by invitation |
NCT05529381 -
Anxiety and Depressive Symptoms in Placenta Previa / Accreta
|
||
Completed |
NCT04264234 -
Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria
|
N/A | |
Completed |
NCT05340205 -
Blood Loss During Cesarean Delivery in Placenta Previa Patients
|
Phase 4 | |
Completed |
NCT03570723 -
Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa
|
N/A | |
Completed |
NCT05283122 -
Mostafa Maged Technique to Control and Prevent the Post-Partum Bleeding From the Lower Uterine Segment in Placenta Previa Cases
|
N/A | |
Withdrawn |
NCT01442207 -
Cerclage for Prevention on Preterm Birth in Women With Placenta Previa
|
Phase 3 | |
Not yet recruiting |
NCT03451136 -
Cervical Length in Cases of Placenta Previa
|
N/A | |
Completed |
NCT02966197 -
Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta
|
N/A | |
Recruiting |
NCT02590484 -
The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta
|
N/A | |
Recruiting |
NCT05802251 -
Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study
|
||
Completed |
NCT03542552 -
Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa
|
Phase 3 | |
Recruiting |
NCT03124472 -
Effect of Uterine Artery Ligation Prior to Uterine Incision in Women With Placenta Previa
|
N/A | |
Recruiting |
NCT03633175 -
Progesterone in Patients With Placenta Previa
|
Phase 2 |